GenoTyping Center of America
PrivateLast Round
Accelerator
Mar 15, 2022
Total Funding Raised
$224,167
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GenoTyping Center of America operates in Healthcare & Life Sciences and is based in Waterville, Maine. Its latest recorded funding round was an Accelerator round in March 2022.
GenoTyping Center of America is a biotechnology company that provides genetic testing and colony management services to support preclinical and drug discovery research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoTyping Center of America Comparables
Compare GenoTyping Center of America with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transnetyx | 83% | |
| Demeetra AgBio | 76% | |
| TransViragen | 74% |
For institutional investors. Book with your work email.
GenoTyping Center of America Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 15, 2022 | ||||
| Grant | Jan 1, 2022 | ||||
| Grant | May 9, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenoTyping Center of America Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dirigo Labs | Accelerator |
| Maine Technology Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 60% MoM, from 1.1K to 1.8K.
- May 15, 2026
Monthly visitors increased 163% MoM, reaching 4.3K.
For institutional investors. Book with your work email.
GenoTyping Center of America Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenoTyping Center of America's valuation, stock price, and market status.
Is GenoTyping Center of America a public or private company?
GenoTyping Center of America is a private company.
What is the current stock price of GenoTyping Center of America?
GenoTyping Center of America is a private company, so its shares have no public market price. Caplight tracks GenoTyping Center of America's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenoTyping Center of America worth (valuation)?
Valuation information for GenoTyping Center of America is not publicly available.
Can I buy GenoTyping Center of America stock?
GenoTyping Center of America shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenoTyping Center of America's last funding round?
GenoTyping Center of America's most recent funding round was Accelerator on March 15, 2022.
Who are the main investors in GenoTyping Center of America?
Key investors in GenoTyping Center of America include Dirigo Labs, Maine Technology Institute.
Will GenoTyping Center of America IPO soon?
No public IPO plans have been announced for GenoTyping Center of America.
How can I track GenoTyping Center of America secondary market activity?
Caplight tracks bids, offers, and trades in GenoTyping Center of America's shares on secondary markets.